Stay updated on EXN407 Safety & Tolerability Clinical Trial

Sign up to get notified when there's something new on the EXN407 Safety & Tolerability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EXN407 Safety & Tolerability Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The sitewide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” and related updates is no longer displayed.
    Difference
    1%
    Check dated 2026-11-08T01:07:56.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T19:23:14.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov page.
    Difference
    1%
    Check dated 2026-10-24T20:21:23.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T21:56:40.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer now shows revision v3.7.1 instead of v3.7.0. The page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-10T21:57:13.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previously visible study details with a minimal error page that includes a Home link and site header/footer.
    Difference
    19%
    Check dated 2026-09-19T20:53:51.000Z thumbnail image

Stay in the know with updates to EXN407 Safety & Tolerability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EXN407 Safety & Tolerability Clinical Trial page.